oral tirzepatide efficacy Safety and of as an add-on to single antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial Tirzepatide Oral vs Injection: Pros,

What we know Eli Lilly, the pharmaceutical company behind GLP-1 injection Zepbound, is working to bring its weight loss drug to the market in pill form

US Holds Largest Share in North America Driven by High Healthcare Spending The US GLP-1 receptor agonist market held the largest share in North America in 2025 due to its patient population, favorable regulatory environment, and high healthcare spending per capita

Oral options include Oral Tirzepatide ($349/mo) for patients who prefer injections-free therapy, or GLP-Squared Oral, combining both agents in capsule form

[17] [18] Proton pump inhibitors (PPIs): Omeprazole or lansoprazole can help with reflux symptoms and dyspepsia

Some bodies respond better to tirzepatide (a dual GLP-1/GIP agonist) or PlexusDx's GLP-Squared injection, which combines both semaglutide and tirzepatide to activate multiple appetite-control pathways simultaneously